Physicochemical Properties
| Molecular Formula | C108H182N44O25S2 |
| Molecular Weight | 2561.01 |
| Exact Mass | 2560.379 |
| CAS # | 2098181-84-9 |
| Related CAS # | KRpep-2d TFA;Biotin-KRpep-2d acetate |
| PubChem CID | 169492932 |
| Appearance | White to light yellow solid powder |
| LogP | -9 |
| Hydrogen Bond Donor Count | 46 |
| Hydrogen Bond Acceptor Count | 36 |
| Rotatable Bond Count | 70 |
| Heavy Atom Count | 179 |
| Complexity | 5660 |
| Defined Atom Stereocenter Count | 20 |
| SMILES | O=C1[C@H](CSSC[C@H](NC([C@@H](NC([C@]2([H])CCCN2C([C@@H](NC([C@@H](NC([C@@H](NC([C@@]([H])(NC([C@@H](NC([C@@H](NC([C@]2([H])CCCN21)=O)CC(C)C)=O)CC1C=CC(=CC=1)O)=O)[C@@H](C)CC)=O)CO)=O)CC1C=CC(=CC=1)O)=O)CC(=O)O)=O)=O)C(C)C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N)CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)C)CCCNC(N)=N |
| InChi Key | PNSDZPKWIOBSHR-WVEXBLHFSA-N |
| InChi Code | InChI=1S/C108H182N44O25S2/c1-8-56(6)81-98(175)146-74(51-153)93(170)143-71(48-58-29-33-60(155)34-30-58)91(168)145-73(50-79(157)158)99(176)151-45-18-28-78(151)96(173)149-80(55(4)5)97(174)147-75(94(171)141-68(25-15-42-131-106(121)122)88(165)139-67(24-14-41-130-105(119)120)86(163)137-65(22-12-39-128-103(115)116)84(161)135-63(82(110)159)20-10-37-126-101(111)112)52-178-179-53-76(100(177)152-46-17-27-77(152)95(172)144-70(47-54(2)3)90(167)142-72(92(169)150-81)49-59-31-35-61(156)36-32-59)148-89(166)69(26-16-43-132-107(123)124)140-87(164)66(23-13-40-129-104(117)118)138-85(162)64(21-11-38-127-102(113)114)136-83(160)62(109)19-9-44-133-108(125)134-57(7)154/h29-36,54-56,62-78,80-81,153,155-156H,8-28,37-53,109H2,1-7H3,(H2,110,159)(H,135,161)(H,136,160)(H,137,163)(H,138,162)(H,139,165)(H,140,164)(H,141,171)(H,142,167)(H,143,170)(H,144,172)(H,145,168)(H,146,175)(H,147,174)(H,148,166)(H,149,173)(H,150,169)(H,157,158)(H4,111,112,126)(H4,113,114,127)(H4,115,116,128)(H4,117,118,129)(H4,119,120,130)(H4,121,122,131)(H4,123,124,132)(H3,125,133,134,154)/t56-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,80-,81-/m0/s1 |
| Chemical Name | 2-[(3R,8R,11S,14S,20S,23S,26S,29S,32S,35S,38S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-[(N-acetylcarbamimidoyl)amino]-2-aminopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-8-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]-29-[(2S)-butan-2-yl]-26-(hydroxymethyl)-23,32-bis[(4-hydroxyphenyl)methyl]-35-(2-methylpropyl)-2,10,13,19,22,25,28,31,34,37-decaoxo-11-propan-2-yl-5,6-dithia-1,9,12,18,21,24,27,30,33,36-decazatricyclo[36.3.0.014,18]hentetracontan-20-yl]acetic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The cyclic structure of KRpep-2d is crucial for its inhibitory action on K-Ras. Key amino acid residues for KRpep-2d's K-Ras inhibitory action include Leu77, Ile9, and Asp12[1]. A427 cells are inhibited by KRpep-2d (10-30 μM), with a proliferation rate of 68.3% (10 μM) and 48.3% (10 μM) [1]. |
| References |
[1]. Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging. Bioorg Med Chem Lett. 2017 Jun 15;27(12):2757-2761. |
Solubility Data
| Solubility (In Vitro) | H2O : ~50 mg/mL (~19.52 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (19.52 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 0.3905 mL | 1.9524 mL | 3.9047 mL | |
| 5 mM | 0.0781 mL | 0.3905 mL | 0.7809 mL | |
| 10 mM | 0.0390 mL | 0.1952 mL | 0.3905 mL |